CITIC SEC: Maintains "buy" rating on TENCENT (00700), fully opens Tencent AI and accelerates international layout.

19/09/2025

Tencent is expected to consolidate its ecological advantages and unleash its commercial potential by leveraging sustained efficient capital investment and an industry-specific full-chain product matrix that allows for multiplicative effects through interconnected links.

CITIC SEC released a research report stating that it maintains a "buy" rating on TENCENT (00700). On September 16-17, 2025, Tencent will host the Global Digital Ecosystem Conference with the theme "Aspiring Intelligence," focusing on the two growth engines of "intelligence and internationalization" and fully opening up Tencent AI and accelerating international layout. The bank believes that Tencent is expected to leverage continuous efficient capital investment and industry practical full-chain product matrix to harness the multiplier effect of connectivity in all aspects, consolidate ecological advantages, and unleash commercial potential.

Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.

Zhejiang Xianju Pharmaceutical (002332.SZ) and related personnel received a warning letter from the Zhejiang Securities Regulatory Bureau.

Maiwei Biology (688062.SH): Application for market approval of 9MW0813 injection has been accepted.

Jiangsu Nhwa Pharmaceutical (002262.SZ): Tetrabromine Hydrochloride Tablets obtained drug registration certificate.

Zhejiang Xianju Pharmaceutical (002332.SZ) and related personnel received a warning letter from the Zhejiang Securities Regulatory Bureau.

Maiwei Biology (688062.SH): Application for market approval of 9MW0813 injection has been accepted.